Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Bill & Melinda Gates Foundation, Seattle, Washington, DC, USA.
Health Policy Plan. 2017 Oct 1;32(8):1174-1184. doi: 10.1093/heapol/czx067.
Little information exists on the cost structure of routine infant immunization services in low- and middle-income settings. Using a unique dataset of routine infant immunization costs from six countries, we estimated how costs were distributed across budget categories and programmatic activities, and investigated how the cost structure of immunization sites varied by country and site characteristics. The EPIC study collected data on routine infant immunization costs from 319 sites in Benin, Ghana, Honduras, Moldova, Uganda, Zambia, using a standardized approach. For each country, we estimated the economic costs of infant immunization by administrative level, budget category, and programmatic activity from a programme perspective. We used regression models to describe how costs within each category were related to site operating characteristics and efficiency level. Site-level costs (incl. vaccines) represented 77-93% of national routine infant immunization costs. Labour and vaccine costs comprised 14-69% and 13-69% of site-level cost, respectively. The majority of site-level resources were devoted to service provision (facility-based or outreach), comprising 48-78% of site-level costs across the six countries. Based on the regression analyses, sites with the highest service volume had a greater proportion of costs devoted to vaccines, with vaccine costs per dose relatively unaffected by service volume but non-vaccine costs substantially lower with higher service volume. Across all countries, more efficient sites (compared with sites with similar characteristics) had a lower cost share devoted to labour. The cost structure of immunization services varied substantially between countries and across sites within each country, and was related to site characteristics. The substantial variation observed in this sample suggests differences in operating model for otherwise similar sites, and further understanding of these differences could reveal approaches to improve efficiency and performance of immunization sites.
关于中低收入国家常规婴儿免疫服务的成本结构,相关信息有限。本研究利用来自六个国家常规婴儿免疫成本的独特数据集,估计了成本在预算类别和规划活动中的分布情况,并调查了免疫接种点的成本结构如何因国家和地点特征而有所不同。EPIC 研究采用标准化方法,从贝宁、加纳、洪都拉斯、摩尔多瓦、乌干达和赞比亚的 319 个地点收集常规婴儿免疫成本数据。对于每个国家,我们从项目角度,按行政级别、预算类别和规划活动来估计婴儿免疫的经济成本。我们使用回归模型来描述每个类别内的成本与地点运营特征和效率水平的关系。(不包括疫苗的)站点级成本占国家常规婴儿免疫成本的 77-93%。劳动力和疫苗成本分别占站点级成本的 14-69%和 13-69%。站点级资源的大部分用于提供服务(基于机构或外展),在六个国家中,占站点级成本的 48-78%。基于回归分析,服务量最高的站点投入疫苗的成本比例更大,每剂疫苗成本相对不受服务量的影响,但随着服务量的增加,非疫苗成本会大幅降低。在所有国家中,与具有相似特征的站点相比,效率更高的站点(与具有相似特征的站点相比)投入劳动力的成本份额更低。各国之间以及每个国家内的各个站点之间的免疫服务成本结构差异很大,并且与站点特征有关。在这个样本中观察到的巨大差异表明,即使是运营模式相似的站点也存在差异,进一步了解这些差异可以揭示提高免疫接种点效率和绩效的方法。